Companies in the precision medicine sector developing innovative solutions and technologies.
Explore 140 recently funded precision medicine companies with verified founder contact information and fundraising data.
Actome focuses on developing emulsion coupling technology for life science research and personalized medicine.
Daisy Genomics is an medtech focused on developing its proprietary long-read DNA sequencing technology for precision medicine applications.
Cx Precision Medicine provides diagnostic screening services intended to provide a path to drug approval during clinical trials.
healiva® is a patient centric Swiss biotech company, delivering precision medicine to improve people’s quality of life.
Radiology augmented GPT to tackle the complexity of precision medicine
Advancing radiotherapeutics to treat solid tumors
Neuro-regenerative personalized medicine is one of the most promising therapies, which needs dedicated uniform standards and regulations.
Tuune is a precision medicine startup that leverages AI and biological testing to match women with contraception.
Precision medicine focused on immune-mediated neuropsychiatric, cardiovascular, long-COVID, and neurodegenerative disorders
Diagnostic-Powered Therapeutics for Brain Health
Phenomics Health operates as a bioinformatics platform-based precision medicine company.
Nome is the Operating System for Personalized Therapies™ — developing custom treatments for rare disease patients, families, and clinicians.
4D Healthware is patient engagement software that makes personalized medicine possible through connected data.
Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.
The precision medicine sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Precision Medicine companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The precision medicine sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 140 precision medicine companies tracked in the VCBacked database.
Companies in the precision medicine sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting precision medicine companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked